Cargando…

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay

This protocol describes an ELISA-based procedure for accurate measurement of SARS-CoV-2 spike protein-receptor binding domain (RBD) neutralization efficacy by murine immune serum. The procedure requires a small amount of S-protein/RBD and angiotensin converting enzyme-2 (ACE2). A high-throughput, si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shalash, Ahmed O., Azuar, Armira, Madge, Harrison Y. R., Modhiran, Naphak, Amarilla, Alberto A., Liang, Benjamin, Khromykh, Alexander A., Watterson, Daniel, Young, Paul R., Toth, Istvan, Skwarczynski, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705285/ https://www.ncbi.nlm.nih.gov/pubmed/34960239 http://dx.doi.org/10.3390/vaccines9121493

Ejemplares similares

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021)

The distinguishing NS5-M114V mutation in American Zika virus isolates has negligible impacts on virus replication and transmission potential
por: Peng, Nias Y. G., et al.
Publicado: (2022)

Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022)

Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern
por: McMillan, Christopher L. D., et al.
Publicado: (2022)

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
por: Amarilla, Alberto A., et al.
Publicado: (2021)

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine
por: McMillan, Christopher L. D., et al.
Publicado: (2021)

SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate
por: Lo, Martin W, et al.
Publicado: (2022)

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
por: Lu, Lantian, et al.
Publicado: (2021)

Inactivation of SARS‐CoV‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light
por: Hobson‐Peters, Jody, et al.
Publicado: (2023)

A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021)

No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing
por: Smits, Nathan, et al.
Publicado: (2021)

Peptide-based synthetic vaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2016)

Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies
por: Schöler, Lara, et al.
Publicado: (2022)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2
por: Albert, Simon, et al.
Publicado: (2021)

Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein
por: Jaberolansar, Noushin, et al.
Publicado: (2017)

Comparison of commercial ELISA assays for quantification of corticosterone in serum
por: Kinn Rød, Anne Marie, et al.
Publicado: (2017)

Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice
por: Scott, Connor A. P., et al.
Publicado: (2021)

Oral Peptide Vaccine against Hookworm Infection: Correlation of Antibody Titers with Protective Efficacy
por: Shalash, Ahmed O., et al.
Publicado: (2021)

The structure of an infectious immature flavivirus redefines viral architecture and maturation
por: Newton, Natalee D., et al.
Publicado: (2021)

Rapid Response Subunit Vaccine Design in the Absence of Structural Information
por: Wijesundara, Danushka K., et al.
Publicado: (2020)

Subversion of Innate Defenses by the Interplay between DENV and Pre-Existing Enhancing Antibodies: TLRs Signaling Collapse
por: Modhiran, Naphak, et al.
Publicado: (2010)

Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells
por: Massai, Luisa, et al.
Publicado: (2013)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

The application of self-assembled nanostructures in peptide-based subunit vaccine development
por: Zhao, Guangzu, et al.
Publicado: (2017)

Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell–cell fusion
por: Thakur, Nazia, et al.
Publicado: (2020)

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
por: Morgan, Mahali S., et al.
Publicado: (2022)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
por: Gardner, Matthew R., et al.
Publicado: (2022)

Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
por: Balingit, Jean Claude, et al.
Publicado: (2020)

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

Lactoferrin quantification in cattle faeces by ELISA
por: Cooke, Andrew S., et al.
Publicado: (2020)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

Ultrasensitive isolation, identification and quantification of DNA–protein adducts by ELISA-based RADAR assay
por: Kiianitsa, Kostantin, et al.
Publicado: (2014)

Highly sensitive ELISA‐based assay for quantification of allergen‐specific IgE antibody levels
por: Karsonova, Antonina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h81ifbu90ik51387iq7ev0ftbh